Integrated Bioinformatics Analysis to Identify Alternative Therapeutic Targets for Alzheimer’s Disease: Insights from a Synaptic Machinery Perspective
Journal of Molecular Neuroscience · 2022-02 · 72 (2) · 273-286
DOI: 10.1007/s12031-021-01893-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Neuroscience, online erschienen am 19.08.2021. Verfasst von Hamid Ceylan. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Faculty of Science, Atatürk University, Erzurum, Turkey. hamid.ceylan@atauni.edu.tr. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 91 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Biology and Genetics, Faculty of Science, Atatürk University, Erzurum, Turkey. hamid.ceylan@atauni.edu.tr.
Zitieren
APA
Ceylan, H. (2022). Integrated Bioinformatics Analysis to Identify Alternative Therapeutic Targets for Alzheimer’s Disease: Insights from a Synaptic Machinery Perspective. Journal of Molecular Neuroscience, 72(2), 273-286. https://doi.org/10.1007/s12031-021-01893-9
Vancouver
Ceylan H. Integrated Bioinformatics Analysis to Identify Alternative Therapeutic Targets for Alzheimer’s Disease: Insights from a Synaptic Machinery Perspective. Journal of Molecular Neuroscience. 2022;72(2):273-286. doi:10.1007/s12031-021-01893-9
BibTeX
@article{Ceylan2022,
author = {Ceylan, Hamid},
title = {Integrated Bioinformatics Analysis to Identify Alternative Therapeutic Targets for Alzheimer’s Disease: Insights from a Synaptic Machinery Perspective},
journal = {Journal of Molecular Neuroscience},
year = {2022},
volume = {72},
number = {2},
pages = {273--286},
doi = {10.1007/s12031-021-01893-9}
}
EUVIMED